Dr Simon Pearce, Professor of Endocrinology, Newcastle University, and Chief Investigator for the trial commented: "This is the first new therapy for Graves' disease to be tested in over 50 years and is a significant step forward in the development of the drug. We are very pleased to be leading the first clinical trial of ATX-GD-59 which has significant potential to treat the underlying cause of this condition for the first time."
What wonderful news for those suffering Graves'. How completely awful that it's the first new therapy to be trialed for over fifty years. Make no mistake; misogyny is at the heart of what keeps so many thyroid patients ill. The poor men who also suffer are just collateral damage
Perhaps Dr Pearce has a T shirt bearing the legend ' this is what a feminist looks like'. Rock on, doc
Sorry, I should have put the link in! Have done so now.
Apitope's ATX-GD-59 has the potential to treat and prevent the production of stimulating antibodies against TSHR (thyroid stimulating hormone receptor) that lead to Graves' disease. The Phase I trial will recruit up to 30 patients and is designed to assess the safety and initial efficacy of the product.
It's a very small trail but it's a very small amount of money but it's still uplifting.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Latest on prescribing T3 in the UK to remain available.
For those Graves (hyperthyroid) patients who may be suffering from eye symptoms
Antithyroid Treatment as Effective as RAI for Graves Relapse and better for TED
